Molecular Templates Inc
General ticker "MTEM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.5M
Molecular Templates Inc does not follow the US Stock Market performance with the rate: -45.3%.
Estimated limits based on current volatility of 5.1%: low 0.11$, high 0.14$
Factors to consider:
- US accounted for 86.9% of revenue in the fiscal year ended 2022-12-31
Short-term MTEM quotes
Long-term MTEM plot
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $38.70MM | $19.75MM | $57.31MM |
Operating Expenses | $118.77MM | $108.62MM | $67.77MM |
Operating Income | $-80.07MM | $-88.87MM | $-10.47MM |
Non-Operating Income | $-2.94MM | $-3.79MM | $2.33MM |
Interest Expense | $3.37MM | $4.78MM | $2.65MM |
R&D Expense | $84.67MM | $82.42MM | $48.88MM |
Income(Loss) | $-83.01MM | $-92.67MM | $-8.13MM |
Taxes | $-3.69MM | $0.05MM | $-0.01MM |
Profit(Loss) | $-79.31MM | $-92.72MM | $-8.12MM |
Stockholders Equity | $65.66MM | $-15.13MM | $4.21MM |
Assets | $192.36MM | $97.55MM | $35.38MM |
Operating Cash Flow | $-30.39MM | $-89.02MM | $-41.82MM |
Capital expenditure | $4.00MM | $3.20MM | $0.20MM |
Investing Cash Flow | $-62.44MM | $95.32MM | $29.09MM |
Financing Cash Flow | $92.59MM | $-0.27MM | $-9.12MM |
Earnings Per Share* | $-21.51 | $-24.69 | $-1.80 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.